Common use

Invokana (canagliflozin) is a prescription oral medication used for the management of type 2 diabetes mellitus in adults. Belonging to the sodium-glucose co-transporter 2 (SGLT2) inhibitor class, Invokana works through a unique insulin-independent mechanism: it blocks the SGLT2 protein in the proximal tubules of the kidneys, which is responsible for reabsorbing approximately 90% of filtered glucose back into the bloodstream. By inhibiting this transporter, canagliflozin causes excess glucose to be excreted in the urine (glycosuria), thereby lowering blood sugar levels without relying on pancreatic insulin secretion. In addition to glycemic control, SGLT2 inhibitors like Invokana have demonstrated cardiovascular and renal protective benefits, including reduced risk of heart failure hospitalization and slowed progression of diabetic kidney disease. Buy Invokana online at DutyPills for affordable canagliflozin tablets with fast, discreet delivery.

Dosage and direction

Invokana is usually taken once daily, before the first meal of the day, to maximize its glucose-lowering effect throughout the day. Swallow the tablet whole with a glass of water; do not crush, split, or chew. The typical starting dose is 100 mg once daily, which may be increased to 300 mg once daily based on your glycemic response, tolerability, and kidney function (eGFR). Dosage adjustments are necessary for patients with moderate renal impairment, and Invokana should not be initiated in patients with an eGFR below 30 mL/min. Regular monitoring of blood glucose, HbA1c, kidney function, and electrolytes is recommended throughout treatment. Maintain adequate fluid intake and follow your healthcare provider’s instructions carefully.

Precautions

Before starting Invokana, inform your doctor if you have chronic kidney disease, liver disease, a history of low blood pressure or volume depletion, recurrent urinary tract infections or genital mycotic infections, a history of diabetic ketoacidosis, or peripheral vascular disease. Because Invokana increases urinary glucose excretion, it can promote genital yeast infections and urinary tract infections; maintain good personal hygiene and report symptoms promptly. Stay well-hydrated throughout the day, especially during hot weather, exercise, or illness, to minimize the risk of dehydration and orthostatic hypotension. Invokana may cause euglycemic diabetic ketoacidosis (DKA with near-normal blood sugar), so be alert for symptoms such as nausea, vomiting, abdominal pain, fatigue, and difficulty breathing. Temporarily discontinue Invokana before major surgery or during periods of prolonged fasting.

Contraindications

Do not use Invokana if you are allergic to canagliflozin or any inactive ingredient in the tablet. It is contraindicated in patients with severe renal impairment (eGFR below 30 mL/min), end-stage renal disease (ESRD), or those on dialysis. Invokana should not be used during pregnancy or breastfeeding unless the potential benefit clearly outweighs the risk, as determined by your healthcare provider. Patients with type 1 diabetes should not take this medication.

Possible side effect

Common side effects of Invokana canagliflozin include genital yeast infections (vulvovaginal candidiasis in women, balanitis in men), urinary tract infections, increased urination (polyuria), thirst, constipation, nausea, and mild dizziness upon standing. These are generally manageable with supportive measures. More serious side effects may include diabetic ketoacidosis (even with normal blood sugar levels), acute kidney injury, severe urinary tract infections (pyelonephritis, urosepsis), hypotension, hyperkalemia, bone fractures (with the 300 mg dose), and Fournier’s gangrene (necrotizing fasciitis of the perineum). Seek immediate medical attention if you experience signs of any serious adverse event.

Drug interaction

Invokana may interact with loop and thiazide diuretics (increasing the risk of dehydration and hypotension), insulin and insulin secretagogues (increasing the risk of hypoglycemia), blood pressure medications, digoxin, lithium, and UGT enzyme inducers such as rifampin, phenytoin, and phenobarbital (which may reduce canagliflozin efficacy). Inform your healthcare provider about all prescription medications, over-the-counter products, and dietary supplements you are taking before starting Invokana.

Missed dose

If you miss your daily dose of Invokana, take it as soon as you remember on the same day. If it is already time for the next day’s dose, skip the missed dose and resume your normal schedule. Do not take two tablets on the same day to compensate for a missed dose.

Overdose

An overdose of Invokana may lead to significant dehydration, electrolyte imbalances, dangerously low blood sugar (particularly if combined with other antidiabetic agents), or acute kidney injury. If you suspect an overdose, seek immediate emergency medical attention. Treatment is supportive and focused on rehydration and correction of electrolyte abnormalities.

Storage

Store Invokana tablets at room temperature between 20 and 25 degrees Celsius, protected from heat, moisture, and direct light. Keep the tablets in their original container and out of the reach of children. Do not use after the expiration date printed on the packaging.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.